-Define QT prolongation and its relationship to Torsades de Pointes (TdP)
-Identify at least two higher risk and lower risk psychiatric medications associated with drug-induced QT prolongation
-Describe clinical factors that may increase susceptibility to drug-induced QT prolongation
-Assess risk the risk of QT prolongation and TdP of select psychiatric medications through the review of short case scenarios